Mjali, A., M. Obaid, B. Matti, and N. Abbas. “Treatment Outcomes of Nilotinib As Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq”. Asian Pacific Journal of Cancer Care, Vol. 7, no. 2, June 2022, pp. 267-72, doi:10.31557/apjcc.2022.7.2.267-272.